Abstract
Increasing use of ultrasonography during pregnancy has uncovered a range of parenchymal lesions within the lung, some of which will, if left, be a cause of morbidity and occasional mortality. These include congenital cystic adenomatoid malformations (CCAM), bronchopulmonary sequestration (BPS), congenital lobar & segmental emphysema and bronchogenic cysts. Adverse antenatal features include mediastinal shift, caval obstruction, and (rarely) hydrops. This review aims to define current thoughts on these lesions and suggest appropriate management.
Keywords: Cystic adenomatoid malformation, bronchopulmonary sequestration, fetal hydrops, lobectomy, Congenital Parenchymal Lesions, segmental emphysema, bronchogenic cysts, embryological origins, mechanical compression, malignancy
Current Respiratory Medicine Reviews
Title: Congenital Parenchymal Lesions of the Lung
Volume: 7 Issue: 2
Author(s): Nada Sudhakaran and Mark Davenport
Affiliation:
Keywords: Cystic adenomatoid malformation, bronchopulmonary sequestration, fetal hydrops, lobectomy, Congenital Parenchymal Lesions, segmental emphysema, bronchogenic cysts, embryological origins, mechanical compression, malignancy
Abstract: Increasing use of ultrasonography during pregnancy has uncovered a range of parenchymal lesions within the lung, some of which will, if left, be a cause of morbidity and occasional mortality. These include congenital cystic adenomatoid malformations (CCAM), bronchopulmonary sequestration (BPS), congenital lobar & segmental emphysema and bronchogenic cysts. Adverse antenatal features include mediastinal shift, caval obstruction, and (rarely) hydrops. This review aims to define current thoughts on these lesions and suggest appropriate management.
Export Options
About this article
Cite this article as:
Sudhakaran Nada and Davenport Mark, Congenital Parenchymal Lesions of the Lung, Current Respiratory Medicine Reviews 2011; 7 (2) . https://dx.doi.org/10.2174/157339811794927815
DOI https://dx.doi.org/10.2174/157339811794927815 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Heterocyclic Compounds as Anti-Inflammatory Agents
Current Bioactive Compounds Essential Roles of Toll-Like Receptors in Atherosclerosis
Current Medicinal Chemistry Efficacy and Cardiovascular Safety of Antidiabetic Medications
Current Drug Safety Anti-Platelet Therapy and Aspirin Resistance – Clinically and Chemically Relevant?
Current Medicinal Chemistry Role of Statins in New-onset Diabetes Mellitus: The Underlying Cause, Mechanisms Involved, and Strategies to Combat
Current Drug Targets The Potential of Statins for Individualized Colorectal Cancer Chemoprevention
Current Drug Targets Recent Patents in Autophagy and Immune Response
Recent Patents on Inflammation & Allergy Drug Discovery Interventions Against Sarcopenia in Older Persons
Current Pharmaceutical Design Editorial [Hot Topic: The Medicinal Chemistry of New Agents to Treat Obesity (Guest Editor: Jinhwa Lee)]
Current Topics in Medicinal Chemistry Regulation of Inflammation: A Review of Recent Advances in Anti- Inflammatory Strategies
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Contemporary Management of Hypertension - How to Optimize Therapy
Cardiovascular & Hematological Disorders-Drug Targets Atheroma Burden and Morphology in Women
Current Pharmaceutical Design Induction of Cytoprotective Genes Through Nrf2 / Antioxidant Response Element Pathway: A New Therapeutic Approach for the Treatment of Inflammatory Diseases
Current Pharmaceutical Design Vulnerable Plaque Versus Vulnerable Patient: Emerging Blood Biomarkers for Risk Stratification
Endocrine, Metabolic & Immune Disorders - Drug Targets Clozapine Safety, 40 Years Later
Current Drug Safety Angiotensin Receptor Blockers in Chronic Heart Failure: Clinical Implications and Molecular Mechanisms
Current Cardiology Reviews Long Noncoding RNA OIP5-AS1 Overexpression Promotes Viability and Inhibits High Glucose-Induced Oxidative Stress of Cardiomyocytes by Targeting MicroRNA-34a/SIRT1 Axis in Diabetic Cardiomyopathy
Endocrine, Metabolic & Immune Disorders - Drug Targets Novel Peptides: An Alternative Approach for the Treatment of Diabetes Mellitus
Current Drug Therapy The Therapeutic Potential of Induced Pluripotent Stem Cells After Stroke: Evidence from Rodent Models
Current Stem Cell Research & Therapy Leptinaemia and Antiendothelial Antibodies in Accelerated Atherosclerosis – Is There a Relationship?
Vascular Disease Prevention (Discontinued)